HYPERKALEMIA: A COMPREHENSIVE REVIEW OF MECHANISMS, RISK FACTORS, AND MANAGEMENT APPROACHES

A clinically relevant disorder that can result in potentially fatal heart consequences is hyperkalemia. Patients with chronic kidney illness, kidney transplant recipients, and those using drugs that upset potassium homeostasis are frequently affected. Hormonal imbalances, transcellular potassium changes, and reduced renal potassium excretion are the causes of the illness. A significant contributing factor is drug-induced hyperkalemia, especially with calcineurin inhibitors, RAAS inhibitors, potassium-sparing diuretics, and treatments including trimethoprim. To avoid major consequences, early detection and proper treatment are crucial. This includes stabilizing cardiac membranes, redistributing potassium, and eliminating excess potassium.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-04-01
DOI
https://doi.org/10.5281/zenodo.19326542
Primary Topic
Potassium and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HYPERKALEMIA: A COMPREHENSIVE REVIEW OF MECHANISMS, RISK FACTORS, AND MANAGEMENT APPROACHES

Mr. Sujit S. Karande*, Ms. Rajnandini C. Koshti, Mr. Ayush A. Shendage, Mr. Shriram G. Kumbhar, Ms. Swati S. Dabhole, Ms. Aditi S. Haval
Zenodo (CERN European Organization for Nuclear Research)
Potassium and Related Disorders
article

HYPERKALEMIA: A COMPREHENSIVE REVIEW OF MECHANISMS, RISK FACTORS, AND MANAGEMENT APPROACHES

Mr. Sujit S. Karande*, Ms. Rajnandini C. Koshti, Mr. Ayush A. Shendage, Mr. Shriram G. Kumbhar, Ms. Swati S. Dabhole, Ms. Aditi S. Haval
article en

Abstract

A clinically relevant disorder that can result in potentially fatal heart consequences is hyperkalemia. Patients with chronic kidney illness, kidney transplant recipients, and those using drugs that upset potassium homeostasis are frequently affected. Hormonal imbalances, transcellular potassium changes, and reduced renal potassium excretion are the causes of the illness. A significant contributing factor is drug-induced hyperkalemia, especially with calcineurin inhibitors, RAAS inhibitors, potassium-sparing diuretics, and treatments including trimethoprim. To avoid major consequences, early detection and proper treatment are crucial. This includes stabilizing cardiac membranes, redistributing potassium, and eliminating excess potassium.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 8%
Potassium and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

HYPERKALEMIA: A COMPREHENSIVE REVIEW OF MECHANISMS, RISK FACTORS, AND MANAGEMENT APPROACHES — Mr. Sujit S. Karande*, Ms. Rajnandini C. Koshti, Mr. Ayush A. Shendage, Mr. Shriram G. Kumbhar, Ms. Swati S. Dabhole, Ms. Aditi S. Haval · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS